Allergic reactions, especially when severe, can be pretty scary. In the case of anaphylaxis, a life-threatening allergic reaction, the treatment typically involves the administration of epinephrine, a ...
Add Yahoo as a preferred source to see more of our stories on Google. The FDA approved Neffy, the first nasal epinephrine drug for treating severe allergies, pictured here in a screenshot from a ...
Add Yahoo as a preferred source to see more of our stories on Google. SolStock/Getty This month, the FDA approved a nasal spray version of the drug epinephrine, a potentially ground-breaking ...
For years, people with severe allergies have been prescribed an epinephrine autoinjector in case of emergency situations. But these injectors—which include the popular EpiPen—involve jabbing a needle ...
ARS Pharmaceuticals, Inc. has announced the addition of neffy® (epinephrine nasal spray) to the formularies of Cigna Healthcare, Navitus Health Systems, and OptumRx, expanding access to approximately ...
DEKALB COUNTY, Ga. - Doctors say a new drug just approved by the US Food and Drug Administration is a potential game changer for those at risk of deadly allergic reactions. Allison Park knows the ...
Good day and welcome to the ARS Pharmaceuticals' neffy (epinephrine nasal spray) FDA Approval Conference call. At this time, all participants are in listen-only mode. After the speakers’ presentation, ...
is the only epinephrine nasal spray used for the emergency treatment of allergic reactions, including anaphylaxis in adults and children 4 years and older who weigh 33 lbs. or greater. is right for ...
On Tuesday, ARS Pharmaceuticals Inc. SPRY announced a leadership transition. Co-founder and CEO Richard Lowenthal stepped ...
25don MSN
ARS Pharmaceuticals (SPRY) stock sinks after-hours after commercial update on Neffy coverage
ARS Pharmaceuticals, Inc. shares fell in after-hours trading on Wednesday after the company provided commercial and financial updates, including no new formulary additions for Neffy in the July 2026 ...
On 9 August, US health officials approved the first nasal spray to treat allergic reactions from drugmaker ARS Pharmaceuticals Inc, an alternative to injectable allergy medications like EpiPen. The ...
The US Food and Drug Administration (FDA) has approved the first nasal medicine to treat severe allergies. On 9 August, US health officials approved the first nasal spray to treat allergic reactions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results